Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. (Nature Medicine, 2017)

(untitled) - West, N; Hegazy, A; Owens, B; Bullers, S; Linggi, B; Buonocore, S; Coccia, M; Görtz, D; This, S; Stockenhuber, K; Pott, J; Friedrich, M; et al.